HomeCompareACWF vs JNJ

ACWF vs JNJ: Dividend Comparison 2026

ACWF yields 2.73% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 ACWF wins by $3.8K in total portfolio value
10 years
ACWF
ACWF
● Live price
2.73%
Share price
$32.79
Annual div
$0.90
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$23.8K
Annual income
$325.98
Full ACWF calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — ACWF vs JNJ

📍 ACWF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodACWFJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, ACWF + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
ACWF pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

ACWF
Annual income on $10K today (after 15% tax)
$232.30/yr
After 10yr DRIP, annual income (after tax)
$277.08/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $426.53/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of ACWF + JNJ for your $10,000?

ACWF: 50%JNJ: 50%
100% JNJ50/50100% ACWF
Portfolio after 10yr
$21.9K
Annual income
$576.88/yr
Blended yield
2.63%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

ACWF
No analyst data
Altman Z
3.7
Piotroski
3/9
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

ACWF buys
0
JNJ buys
0
No recent congressional trades found for ACWF or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricACWFJNJ
Forward yield2.73%3.36%
Annual dividend / share$0.90$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$23.8K$20.0K
Annual income after 10y$325.98$827.78
Total dividends collected$3.0K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: ACWF vs JNJ ($10,000, DRIP)

YearACWF PortfolioACWF Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$10,973$273.30$10,676$355.77+$297.00ACWF
2$12,022$280.28$11,407$389.39+$615.00ACWF
3$13,150$286.97$12,198$426.53+$952.00ACWF
4$14,364$293.37$13,056$467.62+$1.3KACWF
5$15,669$299.49$13,987$513.12+$1.7KACWF
6$17,071$305.32$14,998$563.56+$2.1KACWF
7$18,577$310.88$16,098$619.52+$2.5KACWF
8$20,194$316.18$17,295$681.69+$2.9KACWF
9$21,928$321.20$18,599$750.82+$3.3KACWF
10$23,789$325.98$20,022$827.78+$3.8KACWF

ACWF vs JNJ: Complete Analysis 2026

ACWFStock

The fund generally will invest at least 80% of its assets in the component securities of the underlying index and in investments that have economic characteristics that are substantially identical to the component securities of the underlying index. The underlying index is designed to contain equity securities from the MSCI ACWI Index (the "parent index") that have high exposure to four investment style factors: value, quality, momentum and low size, while maintaining a level of risk similar to that of the parent index.

Full ACWF Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this ACWF vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

ACWF vs SCHDACWF vs JEPIACWF vs OACWF vs KOACWF vs MAINACWF vs ABBVACWF vs MRKACWF vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.